The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
33 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

The University of British Columbia (UBC) is an educational and research institute. The university provides undergraduate, graduate educational programs, and research programs through its schools and faculties. It provides cultural, recreational and social activities for its students. UBC offers educational services through programs such a professional programs, English language pathways, joint academic programs, exchange programs, co-operative education, innovative learning initiatives and distance education programs. The university has its research collaborations with peer institutions, government, non-profit and industry partners.

The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed info

  
Source:
Document ID
GDPH83676D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
The University of British Columbia, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
The University of British Columbia, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
The University of British Columbia, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
The University of British Columbia, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
The University of British Columbia, Medical Devices Deals, 2010 to YTD 201691
The University of British Columbia, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
The University of British Columbia, Pharmaceuticals &Healthcare, Deal Details1217
  Partnerships121
    Sirona Biochem Enters into Research Agreement with University of British Columbia121
    Qu Biologics Enters into Research Agreement with University of British Columbia131
    InMed Pharma Enters into Agreement with University of British Columbia141
    University of British Columbia Enters Into Agreement With Sichuan BoXin LaiTe Biotechnology And Heracles International Investment151
    Cangene Enters Into Research Agreement With University Of British Columbia161
    AlCana Extends Co-Development Agreement With UBC And Alnylam171
    CDRD Enters Into Co-Development Agreement With NGDI-UBC181
    Advaxis Enters Into Co-Development Agreement With University of British Columbia191
    The University Of British Columbia Enters Into Joint Venture Agreement With Max Planck Society201
    Advanced Life Sciences Enters Into Co-Development Agreement With The University of British Columbia211
  Licensing Agreements221
    BirchBioMed Enters into Licensing Agreement with University of British Columbia221
    Cyon Therapeutics Enters into Licensing Agreement with University of British Columbia231
    Cangene Enters Into Licensing Agreement With University of British Columbia241
    Advanced Inhalation Therapies Enters into Licensing Agreement with University of British Columbia251
    Essa Pharma Amends Licensing Agreement with BC Cancer and University of British Columbia262
    The University of British Columbia And CDRD Enter Into Licensing Agreement With Covidien281
The University of British Columbia - Key Competitors291
Key Employees301
Locations And Subsidiaries312
  Head Office311
  Other Locations &Subsidiaries312
Appendix331
  Methodology331
  About GlobalData331
  Contact Us331
  Disclaimer331

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-University-of-British-Columbia-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13662>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-University-of-British-Columbia-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13662>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research